Susceptibility of C57BL/6 mice to tumorigenicity induced by dimethylnitrosamine and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the neonatal bioassay

MLA

Dass, S. B., et al. “Susceptibility of C57BL/6 Mice to Tumorigenicity Induced by Dimethylnitrosamine and 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine in the Neonatal Bioassay.” Cancer Letters, vol. 124, no. 1, Jan. 1998, pp. 105–10. EBSCOhost, https://doi.org/10.1016/S0304-3835(97)00462-X.

APA

Dass, S. B., Hammons, G. J., Bucci, T. J., Heflich, R. H., & Casciano, D. A. (1998). Susceptibility of C57BL/6 mice to tumorigenicity induced by dimethylnitrosamine and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the neonatal bioassay. Cancer Letters, 124(1), 105–110. https://doi.org/10.1016/S0304-3835(97)00462-X

Chicago

Dass, S. B., G. J. Hammons, T. J. Bucci, R. H. Heflich, and D. A. Casciano. 1998. “Susceptibility of C57BL/6 Mice to Tumorigenicity Induced by Dimethylnitrosamine and 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine in the Neonatal Bioassay.” Cancer Letters 124 (1): 105–10. doi:10.1016/S0304-3835(97)00462-X.